Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients.
about
The presence of erythropoietin receptor in parathyroid cells.Secondary hyperparathyroidism and anemia in children treated by hemodialysis.Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response.Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patientsResistance of dialyzed patients to erythropoietin.Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital.Reduced responsiveness to epoetin at re-exposure after prolonged epoetin-free period in anemic hemodialysis patients with end-stage renal disease.Hormonal adjuvants for the treatment of renal anaemia.Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease.Quality of life in dialysis patients from the United Arab EmiratesSearching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry.Study of Red Cell Fragility in Different Stages of Chronic Kidney Disease in Relation to Parathyroid Hormone.Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.Epoetin responsiveness in peritoneal dialysis patients: a multi-center Slovenian study.
P2860
Q33318198-6B530BE7-6376-409C-820C-21400DEF6641Q33637678-181123BB-DC48-4792-9CDB-71108DC609CAQ33770044-803BFC5C-9A62-42F1-B61A-0F65225B13E3Q34639575-FF43A0E5-48F8-482C-AA69-A24F2AB5B13FQ35694046-2D8C6AB8-9200-4B18-85A5-F7AC4189CC1BQ36114718-5E392DCD-7A94-4AD9-BF3B-AA719FCDE3ECQ36147634-E2A0DE96-4B65-4CAC-885A-766549F07126Q36310915-CF23EDC0-6A5D-4EAB-9E81-3A9042EA42D7Q37108009-5B0FB259-56D3-46C9-B039-453181B09F11Q37108512-C9DAF5F2-E995-4998-BDCF-AD078C55EBABQ38034690-C4B446AF-1D8A-4FA3-BED9-300348CF32D0Q40813065-657DF202-766E-481D-95C8-42EC7F767963Q42224863-7520459B-E107-4AF7-B685-7C6CBA126175Q43064681-491F3DE5-E496-42E4-B528-82559169BD1BQ45049672-590D388E-EA1D-4AEE-8A2E-9767F3F02702Q53854122-1EAF7F9C-2278-473B-9C1B-F67CB07E8DE2
P2860
Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of secondary hyperparathy ...... hronic renal failure patients.
@ast
Role of secondary hyperparathy ...... hronic renal failure patients.
@en
Role of secondary hyperparathy ...... hronic renal failure patients.
@nl
type
label
Role of secondary hyperparathy ...... hronic renal failure patients.
@ast
Role of secondary hyperparathy ...... hronic renal failure patients.
@en
Role of secondary hyperparathy ...... hronic renal failure patients.
@nl
prefLabel
Role of secondary hyperparathy ...... hronic renal failure patients.
@ast
Role of secondary hyperparathy ...... hronic renal failure patients.
@en
Role of secondary hyperparathy ...... hronic renal failure patients.
@nl
P356
P1476
Role of secondary hyperparathy ...... chronic renal failure patients
@en
P2093
Kai-Uwe Eckardt
P356
10.1093/NDT/17.SUPPL_5.28
P407
P478
17 Suppl 5
P577
2002-01-01T00:00:00Z